Herbas VPB

Print
EN | LT
LT - 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
EN - 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/445
A61K 31/4468
A61K 45/06
A61K 31/00
G01N 33/68
A61P 25/28
European patent
(11) Number of the document 3436010
(13) Kind of document T
(96) European patent application number 17719380.2
Date of filing the European patent application 2017-03-28
(97) Date of publication of the European application 2019-02-06
(45) Date of publication and mention of the grant of the patent 2021-03-10
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2017/024526
Date 2017-03-28
PCT application publication
(87) Number WO 2017/172757
Date 2017-10-05
Priority applications
(30) Number Date Country code
201662314857 P 2016-03-29 US
1630067 2016-04-04 SE
Inventors
(72)
BURSTEIN, Ethan, US
Grantee
(73) Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA 92130, US
Title
(54) 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
  5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES
Last update date 2021-06-30